The implementation process for rapid molecular blood culture identification can be a complex process for laboratories, medical staff and the antimicrobial stewardship program (ASP). There can be many facets of the process that can easily sink below the surface, which is where GenMark Diagnostics endeavors to ensure a smooth process. By partnering with institutions to provide a comprehensive solution focused on patient-centered-care and antimicrobial stewardship throughout implementation, we can help you stay above the water while adopting a rapid molecular test for diagnosis of bacterial and fungal pathogens causing bloodstream infections.
For any new test, there are several factors to consider both on the laboratory and the stewardship side. The laboratory must consider how to incorporate the new test into their current blood culture workflow, when to perform the test, what the quality control and quality assurance plan will be, how to report the results and who to report them to, how the results will be reported into the laboratory LIS and hospital EHR and lastly, how and when to educate the clinicians.
The IDSA/SHEA guidelines recommend that ASPs develop processes and interventions that assist clinicians in interpreting and responding appropriately to results from rapid diagnostic testing on blood cultures.1 One method of accomplishing this is by using customizable comments along with rapid diagnostic test reporting. When combining the use of a comprehensive panel of pathogens along with Templated Comments and an institution’s antibiogram, the ASP can deliver more opportunities for appropriate optimization of therapy.
A cohesive partnership between the laboratory, ASP and GenMark Infectious Disease Specialists (IDS) has proven to be an effective approach to addressing the challenges with the implementation of blood culture identification (BCID) rapid tests. During this webinar, GenMark Infectious Disease Specialists will provide insights on the successful implementation of the ePlex BCID Panels using real-world examples, while also describing a process for integration of Templated Comments into the patient report to assist clinicians with patient management.
1. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–e77.
What You Will Learn
In this webinar, participants will:
- Learn how an Infectious Disease Specialist (IDS) can assist with the integration of rapid molecular blood culture identification into a laboratory’s current blood culture workflow
- Discover how an IDS is well-positioned to assist in optimizing use of rapid molecular blood culture identification, as current evidence suggests a lack of familiarity with rapid diagnostic testing among clinicians
- Understand how IDS’s can provide strategies for the development of result reporting workflows and institution-specific treatment guidelines for clinicians
Tyler Dodd earned his Doctor of Pharmacy degree at the Samford University McWhorter School of Pharmacy and completed an ASHP-accredited pharmacy practice residency at DCH Regional Medical Center in Tuscaloosa, AL. After completion of residency he completed both SIDP and MAD-ID stewardship certificate programs and obtained board certification in infectious disease pharmacotherapy. He then served as the antimicrobial stewardship program co-chair at DCH Regional with Dr. Albert White. In this role he also acted as a resident preceptor and associate professor for Auburn University Harrison School of Pharmacy. He has now joined GenMark Diagnostics to assist institutions in rapid BCID implementation.
Yvan Caspar is a clinical microbiologist at the bacteriology laboratory of Grenoble Alpes University Hospital (2,100 beds), which also hosts the French National Reference Center for Francisella. His main research focuses on Francisella and tularemia, antibiotic resistance and on the development of new therapeutic strategies. He is also interested in innovative rapid diagnosis technologies, in particular, techniques to improve the management of sepsis and antibiotic stewardship.
Heather Nutting has a passion for microbiology and her extensive laboratory experience has led to her current role as an Infectious Disease Specialist for GenMark Diagnostics. She received a baccalaureate degree with distinction in biology from The Florida State University. Heather spent the subsequent 11 years honing her clinical microbiology skills and achieving certifications as an ASCP microbiology technologist and AMT medical technologist. She also holds licensure in the state of Florida as a supervisor in microbiology and serology/immunology, where she currently resides. Heather has considerable laboratory management experience in both hospital and reference laboratory settings. During her career, she has been involved in the development of Antimicrobial Stewardship Programs and has actively contributed to Infection Prevention initiatives. In her current role, Heather provides support to laboratories and clinicians across the country who seek to implement new molecular technologies, improve patient outcomes, and meet organizational stewardship initiatives.